Skip to main content
FinSpry Logo
FinSpry
CTSO logo
CTSO
(NASDAQ)
Cytosorbents Corporation
$0.58-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cytosorbents (CTSO) Stock Price & Financial Analysis

Cytosorbents Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.53 - $0.59
52-Week High$1.39
52-Week Low$0.50
Open$0.59
Volume253.00K
Average Volume (3M)253.00K
Market Cap36.59M
Shares Outstanding62.75M
Price to Sales (P/S)0.93
Price to Book (P/B)3.81
EV/EBITDA-4.92
Revenue (TTM)36.98M
Net Income (TTM)-10.59M
Free Cash Flow (TTM)-10.21M
EPS (TTM)$-0.17
Profit Margin-28.62%
Operating Margin-38.97%
Return on Equity (ROE)-117.35%
Debt to Equity1.67
50-Day MA$0.68
200-Day MA$0.83
52-Week Change-45.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cytosorbents

What is the current stock price for CTSO?

As of the latest trading session, CTSO stock trades at $0.58. The 52-week range is $0.50–$1.39, with a day range of $0.53–$0.59.

What is the P/E ratio for CTSO?

The P/E ratio (Price-to-Earnings) for CTSO is shown in the Key Statistics section. This valuation metric helps compare Cytosorbents Corporation to industry peers.

Does CTSO pay dividends?

Cytosorbents does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTSO?

Based on 1 analyst, the consensus for CTSO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CTSO?

Cytosorbents's market capitalization is $36.6M, classifying it as a micro-cap company. Cytosorbents operates in the Healthcare sector within the Medical Devices industry.